» Articles » PMID: 27443288

Senicapoc: a Potent Candidate for the Treatment of a Subset of Hereditary Xerocytosis Caused by Mutations in the Gardos Channel

Overview
Journal Haematologica
Specialty Hematology
Date 2016 Jul 23
PMID 27443288
Citations 20
Authors
Affiliations
Soon will be listed here.
Citing Articles

Phospholipid scrambling induced by an ion channel/metabolite transporter complex.

Niu H, Maruoka M, Noguchi Y, Kosako H, Suzuki J Nat Commun. 2024; 15(1):7566.

PMID: 39217145 PMC: 11366033. DOI: 10.1038/s41467-024-51939-w.


The Gárdos Channel and Piezo1 Revisited: Comparison between Reticulocytes and Mature Red Blood Cells.

Petkova-Kirova P, Murciano N, Iacono G, Jansen J, Simionato G, Qiao M Int J Mol Sci. 2024; 25(3).

PMID: 38338693 PMC: 10855361. DOI: 10.3390/ijms25031416.


Stimulation of Hemolysis and Eryptosis by β-Caryophyllene Oxide.

Alghareeb S, Alfhili M, Alsughayyir J Life (Basel). 2023; 13(12).

PMID: 38137900 PMC: 10744803. DOI: 10.3390/life13122299.


Increased KCNN4 Expression Is Correlated With Poor Survival in Lower Grade Glioma.

Lehrer S, Rheinstein P Cancer Diagn Progn. 2023; 3(4):428-432.

PMID: 37405224 PMC: 10316058. DOI: 10.21873/cdp.10235.


New KCNN4 Variants Associated With Anemia: Stomatocytosis Without Erythrocyte Dehydration.

Allegrini B, Jedele S, David Nguyen L, Mignotet M, Rapetti-Mauss R, Etchebest C Front Physiol. 2022; 13:918620.

PMID: 36003639 PMC: 9393219. DOI: 10.3389/fphys.2022.918620.


References
1.
Garneau L, Klein H, Banderali U, Longpra-Lauzon A, Parent L, Sauva R . Hydrophobic interactions as key determinants to the KCa3.1 channel closed configuration. An analysis of KCa3.1 mutants constitutively active in zero Ca2+. J Biol Chem. 2008; 284(1):389-403. DOI: 10.1074/jbc.M805700200. View

2.
Glogowska E, Gallagher P . Disorders of erythrocyte volume homeostasis. Int J Lab Hematol. 2015; 37 Suppl 1:85-91. PMC: 4435826. DOI: 10.1111/ijlh.12357. View

3.
Wiley J, McCulloch K . Calcium ions, drug action and the red cell membrane. Pharmacol Ther. 1982; 18(2):271-92. DOI: 10.1016/0163-7258(82)90070-5. View

4.
Ataga K, Smith W, De Castro L, Swerdlow P, Saunthararajah Y, Castro O . Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood. 2008; 111(8):3991-7. DOI: 10.1182/blood-2007-08-110098. View

5.
Andolfo I, Russo R, Manna F, Shmukler B, Gambale A, Vitiello G . Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis). Am J Hematol. 2015; 90(10):921-6. DOI: 10.1002/ajh.24117. View